April
3, 2009 -- Medtronic, Inc. (NYSE: MDT) announced
earlier this week that it has begun the international launch
of its Driver Sprint RX Coronary Stent System, which received
the CE (Conformité Européene) Mark in February 2009. The
company plans to have its bare-metal stent on a rapid exchange
platform commercially available in more than 100 countries
worldwide. “The Driver stent system has always been very
deliverable,” explained leading stent researcher Dr. C.
Dubois of Leuven University Hospital in Belgium. “Now,
the new Driver Sprint system makes it even more deliverable
for the most challenging anatomy.”
|